Medtronic wins US FDA approval for Onyx 12 liquid embolic system for subdural hematoma treatment

Reuters2026/08/05 22:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Medtronic won US FDA clearance for its Onyx 12 Liquid Embolic System to support surgery for symptomatic subacute or chronic subdural hematoma.
The product targets middle meningeal artery embolization; initial US rollout is set to begin in coming days.
FDA also cleared a 1-minute prep shake time for Onyx 18 and Onyx 34, down from 20 minutes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Medtronic wins US FDA approval for Onyx 12 liquid embolic system for subdural hematoma treatment

You may also like

Crypto prices